Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation - Related Studies

Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation (OPTIDUAL)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2010 by Assistance Publique - Hôpitaux de Paris.
Recruitment status was Recruiting

Study NCT00822536 Information provided by Assistance Publique - Hôpitaux de Paris

First Received on January 13, 2009. Last Updated on June 3, 2010 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Coronary Disease
Ischemia
Thrombosis

More general conditions related to this trial

Interventions listed in this trial

Aspirin and Clopidogrel
Aspirin

Additional drug interventions recognized in this trial

Clopidogrel
Ticlopidine

More general drug interventions related to this trial

Sponsors listed in this trial